Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -3.58 | 6.89 |
| PEG Ratio (TTM) | 0.12 | -0.57 |
| P/S Ratio (TTM) | 0.35 | 5.34 |
| P/B Ratio (TTM) | 1.16 | 17.70 |
| P/FCF Ratio (TTM) | -10.41 | 17.43 |
| Price to 5YR AVG Earnings Ratio | N/A | 25.65 |
| Price to 5YR AVG FCF Ratio | N/A | 14.34 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -17.12% | 5.55% |
| ROE (TTM) | -29.55% | 54.04% |
| Net Profit Margin (TTM) | -9.79% | -139.23% |
| ROIC 5YR AVG | N/A | 7.95% |
Growth (13%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -33.45% | -22.40% | N/A |
| Revenue | 3.57% | 35.87% | N/A |
| Net Income | -32.95% | -25.97% | N/A |
| Cash Flow | -80.46% | -60.96% | N/A |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.24 | 1.62 |
| Quick Ratio (TTM) | 1.60 | 1.36 |
| D/E Ratio (TTM) | N/A | 1.51 |
| Interest Coverage (TTM) | N/A | 8.40 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 1.72 | 5.62 |
| LTL to 5YR AVG FCF | N/A | 1.59 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.13% |